Browse Category

NYSE:IBM 8 December 2025 - 21 December 2025

IBM Stock Week Ahead (Dec. 22–26, 2025): Confluent Deal Fallout, Holiday Trading Risks, and What Could Move International Business Machines

IBM Stock Week Ahead (Dec. 22–26, 2025): Confluent Deal Fallout, Holiday Trading Risks, and What Could Move International Business Machines

IBM shares closed at $300.98 on Dec. 19 after a volatile week, down 2.5% over five sessions. The stock sits near key technical levels as investors weigh the $11 billion Confluent acquisition, announced at a 34% premium and set to close by mid-2026. No major company events are scheduled, but thin holiday liquidity could magnify price swings.
IBM Stock News and Forecast for 2026: IBM Shares Hold Near $301 as Confluent Deal, Credit Outlook, and Analyst Calls Collide (Dec. 20, 2025)

IBM Stock News and Forecast for 2026: IBM Shares Hold Near $301 as Confluent Deal, Credit Outlook, and Analyst Calls Collide (Dec. 20, 2025)

IBM closed at $300.98 on Dec. 19, 2025, near the top of its 52-week range. The company announced an $11 billion deal to acquire Confluent, drawing scrutiny after S&P Global revised IBM’s outlook to negative over leverage concerns. The EU imposed new regulatory oversight, and analysts issued a downgrade on Dec. 20.
IBM Stock (NYSE: IBM) Today: Confluent Deal, AI Momentum, Quantum Roadmap, and Analyst Forecasts on Dec. 16, 2025

IBM Stock (NYSE: IBM) Today: Confluent Deal, AI Momentum, Quantum Roadmap, and Analyst Forecasts on Dec. 16, 2025

IBM shares fell about 1.9% to $302–$303 on Dec. 16, 2025, amid broad large-cap declines. Investors are focused on IBM’s planned $11 billion acquisition of Confluent, expected to close by mid-2026. The company’s market cap stood near $283 billion, with a P/E ratio of 36.06 and a dividend yield of 2.18%. Next earnings are scheduled for Jan. 28, 2026.
Software & SaaS US Stocks Week Ahead (Dec 15–19, 2025): Oracle’s AI Capex Shock, Adobe’s AI Lift, and Deal-Making Signals Investors Are Watching

Software & SaaS US Stocks Week Ahead (Dec 15–19, 2025): Oracle’s AI Capex Shock, Adobe’s AI Lift, and Deal-Making Signals Investors Are Watching

IBM agreed to buy Confluent for $11 billion, while Oracle shares plunged 14% after missing forecasts and raising AI-related spending plans. The Federal Reserve cut rates to 3.50%–3.75%, supporting tech valuations, but investors demanded clearer evidence of AI returns. Adobe beat expectations; ServiceNow was linked to a possible Armis deal.
Cloud Computing US Stocks Week Ahead: AWS, Microsoft Azure, Oracle, ServiceNow and IBM After a Volatile Dec. 8–14, 2025

Cloud Computing US Stocks Week Ahead: AWS, Microsoft Azure, Oracle, ServiceNow and IBM After a Volatile Dec. 8–14, 2025

Oracle shares fell after its cloud revenue rose 34% to $8 billion but its outlook missed Wall Street targets, raising concerns over rising capital spending. Broadcom warned that a shift toward AI could pressure gross margins despite strong demand, fueling volatility. The Federal Reserve cut rates by 25 basis points, adding to uncertainty for growth stocks. Investors are demanding clearer signs of profitable growth in the cloud sector.
US Stock Market Week Ahead (Dec. 15–19, 2025): Delayed Jobs & CPI Data, AI-Trade Volatility, and a High-Stakes Year-End Test

US Stock Market Week Ahead (Dec. 15–19, 2025): Delayed Jobs & CPI Data, AI-Trade Volatility, and a High-Stakes Year-End Test

The Federal Reserve cut rates by 25 basis points on Dec. 10, drawing three dissents and sparking debate over policy direction. The Dow and S&P 500 hit record highs Thursday, but tech stocks slumped late in the week on renewed “AI bubble” concerns. The S&P 500 ended down 0.63% and the Nasdaq fell 1.6% for the week. Investors now await key economic data and earnings.
14 December 2025
Confluent (CFLT) Stock Today: IBM’s $11 Billion Takeover, Analyst Downgrades and Fresh Price Targets – December 10, 2025

Confluent (CFLT) Stock Today: IBM’s $11 Billion Takeover, Analyst Downgrades and Fresh Price Targets – December 10, 2025

Confluent shares traded near $30 on Wednesday, just below IBM’s $31 per-share cash offer announced December 8. The stock is up 26% in the past week after IBM agreed to acquire the company for about $11 billion. Major shareholders representing 62% of voting power back the deal. Closing is expected by mid-2026, pending approvals.
Confluent (CFLT) After Hours: IBM’s $11 Billion Buyout, Wall Street Downgrades and What to Watch Before the Opening Bell on December 10, 2025

Confluent (CFLT) After Hours: IBM’s $11 Billion Buyout, Wall Street Downgrades and What to Watch Before the Opening Bell on December 10, 2025

IBM will acquire Confluent for $31 per share in cash, valuing the deal at about $11 billion. Confluent stock surged after the announcement and closed at $29.90 on December 9, about 3.5% below the offer price. Trading volume spiked to over 55 million shares. Analysts downgraded the stock and a shareholder-rights investigation was launched.
IBM Stock Today: $11 Billion Confluent Deal, Fresh Price Targets and Valuation Jitters in December 2025

IBM Stock Today: $11 Billion Confluent Deal, Fresh Price Targets and Valuation Jitters in December 2025

IBM said Tuesday it will acquire Confluent for $11 billion, its largest deal since Red Hat. IBM shares traded near $311, up 41% year-to-date and about 5% below their 52-week high. The company declared a quarterly dividend of $1.68 per share in October. The Confluent deal is expected to close by mid-2026, pending regulatory approval.
Confluent (CFLT) Stock Surges on IBM’s $11 Billion Takeover – What the $31 Cash Offer Means for Investors on December 9, 2025

Confluent (CFLT) Stock Surges on IBM’s $11 Billion Takeover – What the $31 Cash Offer Means for Investors on December 9, 2025

IBM will acquire Confluent for $31 per share in cash, valuing the deal at about $11 billion, a 34–35% premium to pre-deal prices. Confluent stock is trading near $29.87, with a 3–4% spread to the offer. Several banks downgraded Confluent to Hold/Neutral after the announcement. Shareholder law firms have launched investigations into whether the $31 offer is adequate.
IBM vs Microsoft Stock in December 2025: Which AI Powerhouse Looks Like the Better Buy After IBM’s $11 Billion Confluent Deal?

IBM vs Microsoft Stock in December 2025: Which AI Powerhouse Looks Like the Better Buy After IBM’s $11 Billion Confluent Deal?

IBM announced an $11 billion all-cash deal to acquire Confluent at $31 per share, a 34% premium. IBM stock traded near $310 with a 45% year-to-date return and 2.2% dividend yield. Microsoft shares hovered around $491, with a $3.85 trillion market cap and 17% YTD return. Broader markets remained cautious ahead of the Federal Reserve’s decision.
Confluent (CFLT) Soars on IBM’s $11 Billion Takeover: Deal Terms, Stock Outlook and Analyst Forecasts After December 8, 2025 Rally

Confluent (CFLT) Soars on IBM’s $11 Billion Takeover: Deal Terms, Stock Outlook and Analyst Forecasts After December 8, 2025 Rally

IBM will acquire Confluent for $31 per share in cash, valuing the company at about $11 billion. Confluent stock jumped nearly 29% on December 8, trading close to the buyout price after the deal was announced. Both boards approved the agreement, with major shareholders backing the transaction. Closing is expected by mid-2026, pending shareholder and regulatory approval.
Most Active Stocks Today: Nvidia, Tesla, Netflix, Warner Bros. Discovery and SoFi Lead US Market Action (Dec. 8, 2025)

Most Active Stocks Today: Nvidia, Tesla, Netflix, Warner Bros. Discovery and SoFi Lead US Market Action (Dec. 8, 2025)

Nvidia, Tesla, Netflix, Warner Bros. Discovery, SoFi, IBM, and Confluent led US trading volume as Wall Street watched for the Fed’s final 2025 policy decision. Nvidia traded over 140 million shares, while Warner Bros. Discovery surged on a takeover bid. Netflix moved on a potential $108 billion media deal. SoFi fell after announcing a $1.5 billion share sale.
Biggest Stock Gainers Today: Biotech Breakouts and IBM–Confluent Deal Lead U.S. Market Movers (December 8, 2025)

Biggest Stock Gainers Today: Biotech Breakouts and IBM–Confluent Deal Lead U.S. Market Movers (December 8, 2025)

U.S. stocks were little changed Monday ahead of the Federal Reserve meeting, with the S&P 500 and Dow down 0.03% and the Nasdaq 100 up 0.07%. Small-cap stocks surged, led by biotech firms on clinical trial results and M&A news. Cemtrex soared 134%, Structure Therapeutics 97%, and Wave Life Sciences 92%. The Russell 2000 rose 0.55% intraday.
IBM to Acquire Confluent for $11 Billion in All‑Cash Deal to Power Enterprise AI Data Streaming

IBM to Acquire Confluent for $11 Billion in All‑Cash Deal to Power Enterprise AI Data Streaming

IBM will acquire Confluent in an all-cash deal valued at $11 billion, paying $31 per share. Both boards approved the transaction, with Confluent shareholders holding 62% of voting power backing the deal. Shares of Confluent jumped up to 30% in pre-market trading, while IBM stock slipped about 2%. The companies expect to close the deal by mid-2026, pending regulatory and shareholder approval.
IBM Stock After the $11 Billion Confluent Deal: Price, Forecasts and AI Strategy in December 2025

IBM Stock After the $11 Billion Confluent Deal: Price, Forecasts and AI Strategy in December 2025

IBM said December 8 it will acquire Confluent Inc. for $11 billion in cash, or $31 per share. IBM shares traded flat to slightly lower near $308 following the announcement, while Confluent jumped over 20%. The deal is expected to close by mid-2026. IBM’s market cap stands near $290 billion, with shares up more than 40% year-to-date.
IBM’s $11 Billion Confluent Acquisition: How Real‑Time Data Supercharges Its AI and Cloud Strategy

IBM’s $11 Billion Confluent Acquisition: How Real‑Time Data Supercharges Its AI and Cloud Strategy

IBM will acquire Confluent in an all-cash deal valued at $11 billion, paying $31 per share, the companies announced December 8, 2025. The offer represents a roughly 50% premium to Confluent’s October 7 closing price. IBM will use existing cash to fund the purchase. The deal is expected to close by mid-2026, pending shareholder and regulatory approval.
1 4 5 6 7 8 11
Go toTop